1. Evaluation of similar biotherapeutic products (SBPs): scientific principles and their implementation;Knezevic;Biologicals,2011
2. Access to biotherapeutic products including similar biotherapeutic products and ensuring their quality, safety and efficacy;Resolution WHA67.21,2014
3. WHO standards for biotherapeutics, including biosimilars: an example of the evaluation of complex biological products;Knezevic;Ann. N. Y. Acad. Sci.,2017
4. WHO/KFDA joint workshop on implementing WHO guidelines on evaluating similar biotherapeutic products, Seoul, Republic of Korea, 24–26 August, 2010;Wadhwa;Biologicals,2011
5. On behalf of the participants of the WHO implementation workshop of regulatory expectations and assessment of biotherapeutics in Africa region. Meeting report;Rodgers,2015